Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  A M A Archives of Ophthalmology

• Publication date

  1995-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOPHT.1995.01100100045026PMID 7575256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.

  1993cited by this paper
• Divergent approaches to the management of corneal ulcers.

  1992cited by this paper
• Community care of corneal ulcers.

  1992cited by this paper
• Community care of corneal ulcers.

  1992cited by this paper
• Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis.

  1991cited by this paper
• The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses.

  1989cited by this paper
• Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

  1988cited by this paper
• Gaps and perspectives of new fluoroquinolones.

  1988cited by this paper
• 1 – The Quinolones: History and Overview

  1988cited by this paper
• Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.

  1988cited by this paper
• Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

  1987cited by this paper
• Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.

  1987cited by this paper
• Clinical significance of serum thermolysin-like metalloendopeptidase and its relationship to serum angiotensin converting enzyme in sarcoidosis.

  1987cited by this paper
• Norfloxacin: its potential in clinical practice.

  1987cited by this paper
• In vitro activity of ciprofloxacin against gram-positive cocci.

  1987cited by this paper
• In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.

  1987cited by this paper
• In vitro activity of ciprofloxacin against gram-positive cocci.

  1987cited by this paper
• Longitudinal data analysis for discrete and continuous outcomes.

  1986cited by this paper
• The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

  1985cited by this paper
• Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus

  1985cited by this paper
• In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

  1984cited by this paper
• Demographic and predisposing factors in corneal ulceration.

  1983cited by this paper
• Decision-making in the management of microbial keratitis.

  1981cited by this paper
• A Friedman-Type Rank Test for Main Effects in a Two-Factor ANOVA

  1980cited by this paper
• Spectrum of microbial keratitis in South Florida.

  1980cited by this paper
• Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms.

  1979cited by this paper
• Sample size requirements for evaluating a conservative therapy.

  1978cited by this paper
• Preferred Routes of Antibiotic Administration in Treatment of Bacterial Ulcers of the Cornea

  1973cited by this paper
• Early Diagnosis and Therapy of Bacterial Corneal Ulcers

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Chi-square tests with one degree of freedom

  1963cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Managing corneal foreign body injuries in a primary eye care setting

  2025cites this paper
• Long-term trends in bacterial keratitis in Toronto: a 21-year retrospective review.

  2025cites this paper
• Topical antibiotics for treating bacterial keratitis: a network meta-analysis.

  2025cites this paper
• New Insight Into the Neuroimmune Interplay In Pseudomonas aeruginosa Keratitis

  2025cites this paper
• New Insight Into the Neuroimmune Interplay In Pseudomonas aeruginosa Keratitis.

  2025cites this paper
• Pseudomonas Keratitis: From Diagnosis to Successful Deep Anterior Lamellar Keratoplasty

  2024cites this paper
• Insights into ocular therapeutics: a comprehensive review of anatomy, barriers, diseases and nanoscale formulations for targeted drug delivery

  2024cites this paper
• A Review of the Categorizations of Mild, Moderate, and Severe Bacterial Keratitis Ulcers and Day-1 Treatment Regimen When Using the Topical Fluoroquinolones 0.3% Ciprofloxacin and 0.3% Ofloxacin

  2023influential citation
• Safety and efficacy of fortified antibiotics and fluoroquinolones for the treatment of bacterial keratitis: A meta-analysis.

  2023cites this paper
• Controllable Errors in the Management of Infectious Keratitis.

  2023cites this paper
• Ocular Bacterial Infections: A Ten-Year Survey and Review of Causative Organisms Based on the Oklahoma Experience

  2023cites this paper
• Antibiotherapie locale en ophtalmologie

  2022cites this paper
• The clinical treatment of bacterial keratitis: A review of drop instillation regimes.

  2022cites this paper
• Simultaneous Estimation of Ketorolac Tromethamine and Ofloxacin

  2022cites this paper
• A Literature-Based Review and Analysis of the Pharmacodynamics of the Dose Frequency of Topical 0.3% Ciprofloxacin and 0.3% Ofloxacin in the Day-1 Treatment of Bacterial Keratitis

  2022cites this paper
• Practical use and prescription of ocular medications in children and infants

  2021cites this paper
• Melting corneal ulcers (keratomalacia) in dogs: A 5-year clinical and microbiological study (2014-2018).

  2021cites this paper
• Bacterial, Chlamydial, and Mycobacterial Infections

  2021cites this paper
• Urgent unmet needs in the care of bacterial keratitis: An evidence-based synthesis.

  2021cites this paper
• Targeting Inflammation Driven by HMGB1 in Bacterial Keratitis—A Review

  2021cites this paper
• Seven-Year Analysis of Microbial Keratitis Tendency at an Ophthalmology Department in Poland: A Single-Center Study

  2020cites this paper
• Neuro-ophthalmology and Strabismus

  2020cites this paper
• Effects of Glycyrrhizin on Multi-Drug Resistant Pseudomonas aeruginosa

  2020cites this paper
• Treatment of Severe Infectious Keratitis With Scleral Contact Lenses as a Reservoir of Moxifloxacin 0.5%

  2020cites this paper
• Repeatability and Reproducibility of Slit Lamp, Optical Coherence Tomography, and Scheimpflug Measurements of Corneal Scars

  2019cites this paper
• Ophthalmika

  2019cites this paper
• Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies

  2019cites this paper
• An 11-year analysis of microbial keratitis in the South West of England using brain–heart infusion broth

  2019cites this paper
• The Spectrum of Microbial Keratitis: An Updated Review

  2019cites this paper
• Frontline Science: Employing enzymatic treatment options for management of ocular biofilm‐based infections

  2019cites this paper
• Association of Postfungal Keratitis Corneal Scar Features With Visual Acuity.

  2019cites this paper
• Acute Redness of the Eye

  2018cites this paper
• Empirical treatment of bacterial keratitis: an international survey of corneal specialists

  2017cites this paper
• Update on the Management of Infectious Keratitis.

  2017cites this paper
• A Novel Sensitive Method for Quantitative Determination of Tobramycin by Spectrophotometer using Diphenylamine

  2017cites this paper
• Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital

  2017cites this paper
• Protective efficacy of a peptide derived from a potential adhesin of Pseudomonas aeruginosa against corneal infection.

  2016cites this paper
• Evidence-Based Treatment of Fungal Keratitis.

  2016cites this paper
• Demographic profile of Suppurative keratitis

  2016cites this paper
• Fungal Infections in Boston Keratoprosthesis Patients: Lessons Learned and Novel Developments on the Horizon

  2016cites this paper
• Gatifloxacin 0.3% Versus Fortified Tobramycin–Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial

  2016cites this paper
• Corneal Collagen Cross-Linking for Infectious Keratitis: A Systematic Review and Meta-Analysis

  2016cites this paper
• Besifloxacin Ophthalmic Suspension 0.6% in the Treatment of Bacterial Keratitis: A Retrospective Safety Surveillance Study

  2015cites this paper
• Rising fluoroquinolone resistance rates in corneal isolates: implications for the wider use of antibiotics within the community

  2015cites this paper
• Topical corticosteroids as adjunctive therapy for bacterial keratitis.

  2014cites this paper
• Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials

  2014cites this paper
• Therapeutic interventions for microbial keratitis

  2014cites this paper
• Advances in the Diagnosis and Management of Infectious Keratitis

  2014cites this paper
• Study of epidemiological characters, predisposing factors and treatment outcome of corneal ulcer patients

  2014cites this paper
• Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.

  2013cites this paper
• Chronic Ocular Hypertension after Treated Multifocal Bacterial Keratitis

  2013cites this paper
• Microbiota Evaluation of Patients With a Boston Type I Keratoprosthesis Treated With Topical 0.5% Moxifloxacin and 5% Povidone–Iodine

  2013cites this paper
• Kératites bactériennes

  2013cites this paper
• A Study on Bacterial, Fungal and Parasitic Agents inInfectious Keratitis Patients due to Trauma in a Tertiary Care Ophthalmic Hospital.

  2013cites this paper
• Initial treatment of Pseudomonas aeruginosa contact lens-associated keratitis with topical chloramphenicol, and effect on outcome

  2013cites this paper
• Clinical profile and visual morbidity of patients with infectious keratitis in rural area of Pawapuri, Bihar, India: A hospital based prospective study

  2013cites this paper
• Spectrum of Bacterial Keratitis at a Tertiary Eye Care Centre in India

  2013cites this paper
• Staphylococcus epidermidis Susceptibilities of Ocular Isolates of Molecular Characterization and Antibiotic

  2013cites this paper
• Galectin-1–Mediated Suppression of Pseudomonas aeruginosa–Induced Corneal Immunopathology

  2013cites this paper
• Pharmacological treatment for infectious corneal ulcers

  2013cites this paper
• Management and treatment of contact lens-related Pseudomonas keratitis

  2012cites this paper
• Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.

  2012cites this paper
• Therapeutic Effect of Corneal Collagen Cross-Linking in Necrotizing Herpetic Stromal Keratitis, Report of Two Cases

  2012cites this paper
• Non-viral microbial keratitis in children.

  2012cites this paper
• Fluoroquinolones

  2012cites this paper
• Design and Evaluation of Ciprofloxacin Hydrochloride Ocular Inserts

  2011cites this paper
• Monotherapy versus fortified antibiotics for bacterial keratitis.

  2011cites this paper
• Management of corneal perforation.

  2011cites this paper
• The efficacy and safety of 0.5% Levofloxacin versus fortified Cefazolin and Amikacin ophthalmic solution for the treatment of suspected and culture-proven cases of infectious bacterial keratitis: a comparative study

  2011cites this paper
• Deep anterior lamellar keratoplasty for resolved hydrops.

  2011cites this paper
• Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.

  2011cites this paper
• [Main pathogens and in vitro antimicrobial susceptibility in bacterial keratitis: 5-year study, 2005-2009].

  2011cites this paper
• In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes.

  2011cites this paper
• Post-traumatic Infectious Endophthalmitis.

  2011cites this paper
• Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins

  2011cites this paper
• In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review

  2011cites this paper
• Epidemiology of ulcerative keratitis in Northern California.

  2010cites this paper
• Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India

  2010cites this paper
• CHAPTER 53 – Infections of the eye

  2010cites this paper
• Limitations of Current Antibiotics for the Treatment of Bacterial Conjunctivitis

  2010cites this paper
• Randomized Clinical Study for Comparative Evaluation of Fourth-Generation Fluoroquinolones With the Combination of Fortified Antibiotics in the Treatment of Bacterial Corneal Ulcers

  2010cites this paper
• Inhibition of Macrophage Migration Inhibitory Factor Ameliorates Ocular Pseudomonas aeruginosa-Induced Keratitis

  2010cites this paper
• In Vitro Susceptibility of Bacterial Keratitis Isolates to Fourth-Generation Fluoroquinolones

  2010cites this paper
• Efficacy of Besifloxacin in an Early Treatment Model of Methicillin-Resistant Staphylococcus Aureus Keratitis

  2010cites this paper
• Community Opinions in the Management of Corneal Ulcers and Ophthalmic Antibiotics: A Survey of 4 States

  2010cites this paper
• Population biology of Propionibacterium acnes and Pseudomonas aeruginosa in ophthalmic infections and the development of novel diagnostic tools

  2009cites this paper
• Microbial Keratitis in Kingdom of Bahrain: Clinical and Microbiology Study

  2009cites this paper
• Úlcera corneal bacteriana tratada con antibiótico intraestromal: Modelo experimental in vivo

  2009cites this paper
• Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital

  2009cites this paper
• [Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].

  2009cites this paper
• Trends in Resistance to Ciprofloxacin, Cefazolin, and Gentamicin in the Treatment of Bacterial Keratitis

  2008cites this paper
• Microbial keratitis in Thailand: a survey of common practice patterns.

  2008cites this paper
• Age-related Risk Factors, Culture Outcomes, and Prognosis in Patients Admitted With Infectious Keratitis to Two Dutch Tertiary Referral Centers

  2008cites this paper
• Medical management approach to infectious keratitis

  2008cites this paper
• Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.

  2008cites this paper
• Corticosteroids for bacterial corneal ulcers

  2008cites this paper
• Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones

  2008cites this paper
• In Vitro Susceptibilities of Bacterial Isolates From Conjunctival Flora to Gatifloxacin, Levofloxacin, Tosufloxacin, and Moxifloxacin

  2008cites this paper
• Bacterial Keratitis - Empirical Treatment or Therapy According to Antibiotic Sensitivity Report

  2008cites this paper
• Antibiothérapie locale en ophtalmologie

  2008cites this paper